Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. | NAR Cancer | 2023 | 37609662 | PubTator, text mining | PubMed |
| RNF4 and USP7 cooperate in ubiquitin-regulated steps of DNA replication. | Open Biol | 2023 | 37607592 | PubTator, text mining | PubMed |
| MicroRNA-9-1 Attenuates Influenza A Virus Replication via Targeting Tankyrase 1. | J Innate Immun | 2023 | 37607510 | PubTator, text mining | PubMed |
| AXIN1 bi-allelic variants disrupting the C-terminal DIX domain cause craniometadiaphyseal osteosclerosis with hip dysplasia. | Am J Hum Genet | 2023 | 37582359 | PubTator, text mining | PubMed |
| Iron promotes glycolysis to drive colon tumorigenesis. | Biochim Biophys Acta Mol Basis Dis | 2023 | 37579983 | PubTator, text mining | PubMed |
| Investigation of Mutated in Colorectal Cancer (MCC) Gene Family Evolution History Indicates a Putative Role in Th17/Treg Differentiation. | Int J Mol Sci | 2023 | 37569317 | PubTator, text mining | PubMed |
| The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies. | Cancers (Basel) | 2023 | 37568705 | PubTator, text mining | PubMed |
| Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling. | Pharmaceuticals (Basel) | 2023 | 37513937 | PubTator, text mining | PubMed |
| Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking. | Pharmaceuticals (Basel) | 2023 | 37513925 | PubTator, text mining | PubMed |
| PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages. | Pathogens | 2023 | 37513811 | PubTator, text mining | PubMed |
| Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. | Microorganisms | 2023 | 37512809 | PubTator, text mining | PubMed |
| Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. | Cells | 2023 | 37508568 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Principles and Applications of the Proteasome. | Cells | 2023 | 37508510 | PubTator, text mining | PubMed |
| Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia. | Sci Rep | 2023 | 37507442 | PubTator, text mining | PubMed |
| Escin Activates Canonical Wnt/β-Catenin Signaling Pathway by Facilitating the Proteasomal Degradation of Glycogen Synthase Kinase-3β in Cultured Human Dermal Papilla Cells. | Curr Issues Mol Biol | 2023 | 37504289 | PubTator, text mining | PubMed |
| Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts. | FEBS Open Bio | 2023 | 37499040 | PubTator, text mining | PubMed |
| Role of β-catenin in PD-L1 expression of nasopharyngeal carcinoma. | Heliyon | 2023 | 37496925 | PubTator, text mining | PubMed |
| The Increased TIGIT-Expressing CD3+CD56+ Cells Are Associated with Coronary Artery Disease and Its Inflammatory Environment. | Inflammation | 2023 | 37491572 | PubTator, text mining | PubMed |
| [Research Progress on the Protective Effect of Intestinal Flora on Radiation-induced Lung Injury in Thoracic Tumors]. | Zhongguo Fei Ai Za Zhi | 2023 | 37488084 | PubTator, text mining | PubMed |
| Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers. | Onco Targets Ther | 2023 | 37485307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=10